Organogenesis Holdings, Inc. (ORGO) CEO Gary Gillheeney on Q2 2020 Results - Earnings Call Transcript

Organogenesis Holdings, Inc. (NASDAQ:ORGO) Q2 2020 Earnings Conference Call August 10, 2020 5:00 PM ET

Company Participants

Gary Gillheeney - President, Chief Executive Officer & Director
Timothy Cunningham - Chief Financial Officer

Conference Call Participants

Matthew Miksic - Crédit Suisse
Ryan Zimmerman - BTIG
Richard Newitter - SVB Leerink
Steven Lichtman - Oppenheimer

Operator

Good afternoon, ladies and gentlemen, and welcome to the Second Quarter 2020 Earnings Conference Call for Organogenesis Holdings Inc. At this time, all participants have been placed on - are in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay shortly.

Before we begin, I would like to remind everyone that our remarks today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including the risks and uncertainties described in the company's filings with the Securities and Exchange Commission including Item 1A, Risk Factors, of the company's most recent annual and quarterly report. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Although it may voluntarily do so from time to time, the company undertakes no commitment to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. This call will also include references to certain financial measures that are not calculated in accordance with generally accepted accounting principles, or GAAP. We generally refer to this as non-GAAP financial measures. Reconciliations of those non-GAAP financial measures to the most comparable measures calculated and presented in accordance with GAAP are available in the earnings press release on the Investor Relations portion of our website.